In vitro and in vivo effects of deferoxamine in neonatal acute leukemia

Z Estrov, A Tawa, XH Wang, ID Dube, H Sulh, A Cohen… - 1987 - ashpublications.org
A six week old infant with acute leukemia failed to attain remission with chemotherapy.
Because we previously demonstrated that the iron chelator deferoxamine (DFO) has …

Involvement of multiple signaling pathways in follicular lymphoma transformation: p38-mitogen-activated protein kinase as a target for therapy

…, SL Perkins, ID Dube… - Proceedings of the …, 2003 - National Acad Sciences
… Here, we have used expression profiling for the identification of important genes/pathways
involved in FL transformation. We studied an initial cohort of matched pairs of FLs and their …

Clinicopathologic manifestations and breakpoints of the t (3; 5) in patients with acute nonlymphocytic leukemia.

SC Raimondi, ID Dube, MB Valentine, J Mirro Jr… - Leukemia, 1989 - europepmc.org
Acquired chromosomal rearrangements in acute nonlymphocytic leukemia (ANLL) have
been linked to specific clinicopathologic features that suggest new disease subtypes. In this …

p53 gene mutations in sequential oral epithelial dysplasias and squamous cell carcinomas

…, JA Regezi, G Bradley, ID Dube… - The Journal of …, 2000 - Wiley Online Library
Previous studies of oral cancer have suggested that alterations of the p53 tumour suppressor
gene occur early in the precancerous stage of development. However, these observations …

A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t (10; 14)

ID Dube, S Kamel-Reid, CC Yuan, M Lu, X Wu… - 1991 - ashpublications.org
… Comparison with murine HOX-2.6, for example, showed identity or conservative changes at
… Furthermore, there was identity at 13 of the 17 amino acids that are less strictly conserved in …

Gene therapy: here to stay.

ID Dube, D Cournoyer - CMAJ: Canadian Medical Association …, 1995 - ncbi.nlm.nih.gov
Dube is scientific director of the Gene Therapy Program (hematology/oncology), Toronto
Hospital, and associate professorofpathologyand pediatrics, Universityof Toronto, Toronto, Ont. …

Genetically Corrected Autologous Stem Cells Engraft, But Host Immune Responses Limit Their Utility in Canine-L-iduronidase Deficiency

…, R Foster, D Kohn, R Shull, ID Dubé - Blood, The Journal …, 1999 - ashpublications.org
… In this study we infused five homozygous affected α-ID–deficient pups with autologous
marrow genetically corrected to express high levels of functional α-ID. Our results demonstrate …

Characterization and developmental expression of Tlx-1, the murine homolog of HOX11

K Raju, S Tang, ID Dubé, S Kamel-Reid… - Mechanisms of …, 1993 - Elsevier
HOX11, a human homeobox gene with putative oncogenic potential, was originally discovered
at the chromosome 10 breakpoint in T-cell acute lymphoblastic leukemias bearing the …

Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors

…, JE Dick, SA Kruth, VE Valli, S Kamel-Reid, ID Dubé - 1992 - ashpublications.org
Retroviral infection of bone marrow cells in long-term marrow cultures (LTMCs) offers several
theoretical advantages over other methods for gene transfer into hematopoietic stem cells. …

Deregulation of NPM and PLZF in a variant t (5; 17) case of acute promyelocytic leukemia

JL Hummel, RA Wells, ID Dubé, JD Licht… - Oncogene, 1999 - nature.com
… When study of the t(5;17) APL translocation began, the identity of the RARα fusion partner
was unknown. Due to limited patient material, somatic cell hybrid lines were established and …